Flamel Technologies S.A. - Pharmaceuticals & Healthcare - Deals and Alliances ProfileSummaryFlamel Technologies S.A. (Flamel) is a biopharmaceutical company, developing two polymer-based drug delivery technologies for the improvement of medical applications. The key technologies of the company includes Medusa nanoparticulate technology, Micropump technology and Trigger-Lock technology. It develops The company also develops drugs like Interferon, FT-105 and Interleukin based on its Medusa technology. The company holds 338 patents over its innovations and developments. The company is headquartered at Venissieux Cedex, FranceGlobal Market Direct's Flamel Technologies S.A. - Pharmaceuticals & Healthcare - Deals and Alliances Profile is an essential source for company data and information. The profile examines the company's key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy as well as highlighting the company's major recent financial deals. Scope- Provides key company information for business intelligence needs- Gives information on the company's major recent financial deals including Mergers and Acquisitions, asset transactions, PE/VC deals, equity offerings, debt offerings and partnerships. - Data is supplemented with details on the company's history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.Reasons to buy- A quick 'one-stop-shop' to understand the company.- Support sales activities by understanding your customers' businesses.- Qualify prospective partners and suppliers.- Understand and respond to your competitors' business structure, strategy and prospects through.- Understanding the key deals which have shaped the company.

1. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Flamel Technologies S.A. - Pharmaceuticals & Healthcare - Deals
and Alliances Profile
Published on July 2009
Report Summary
Flamel Technologies S.A. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Summary
Flamel Technologies S.A. (Flamel) is a biopharmaceutical company, developing two polymer-based drug delivery technologies for the
improvement of medical applications. The key technologies of the company includes Medusa nanoparticulate technology, Micropump
technology and Trigger-Lock technology. It develops The company also develops drugs like Interferon, FT-105 and Interleukin based
on its Medusa technology. The company holds 338 patents over its innovations and developments. The company is headquartered at
Venissieux Cedex, France
Global Market Direct's Flamel Technologies S.A. - Pharmaceuticals & Healthcare - Deals and Alliances Profile is an essential source
for company data and information. The profile examines the company's key business structure and operations, history and products,
and provides summary analysis of its key revenue lines and strategy as well as highlighting the company's major recent financial
deals.
Scope
- Provides key company information for business intelligence needs
- Gives information on the company's major recent financial deals including Mergers and Acquisitions, asset transactions, PE/VC
deals, equity offerings, debt offerings and partnerships.
- Data is supplemented with details on the company's history, key executives, business description, locations and subsidiaries as well
as a list of products and services and the latest available company statement.
Reasons to buy
- A quick 'one-stop-shop' to understand the company.
- Support sales activities by understanding your customers' businesses.
- Qualify prospective partners and suppliers.
- Understand and respond to your competitors' business structure, strategy and prospects through.
- Understanding the key deals which have shaped the company.
Table of Content
Table Of Contents
Table Of Contents 2
List of Tables 3
Flamel Technologies S.A. - Pharmaceuticals & Healthcare - Deals and Alliances Profile Page 1/4

2. Find Industry reports, Company profiles
ReportLinker and Market Statistics
List of Figures 3
Flamel Technologies S.A., Pharmaceuticals & Healthcare, Deals By Year, 2004 to YTD 2009 4
Flamel Technologies S.A., Pharmaceuticals & Healthcare Deals By Type, 2004 to YTD 2009 5
Flamel Technologies S.A., Pharmaceuticals & Healthcare, Deals By Region, 2004 to YTD 2009 6
Flamel Technologies S.A., Pharmaceuticals & Healthcare, Deals By Sector, 2004 to YTD 2009 7
Flamel Technologies S.A., Pharmaceuticals & Healthcare, Deals Summary, 2004 to YTD 2009 8
Flamel Technologies S.A., Pharmaceuticals & Healthcare, Deal Details 9
Partnerships 9
Flamel Technologies Enters Into Licensing Agreement With Merck Serono 9
Flamel Technologies Enters Into Licensing Agreement With Merck Serono 10
Flamel Technologies Enters Into Agreement With Wyeth Pharmaceuticals 11
Flamel Technologies Entered Into Co-Marketing Agreement With RHEI Pharmaceuticals 12
Flamel Terminates Agreement With TAP Pharmaceutical 13
Flamel Terminates Licensing Agreement With Biovail 14
Flamel Entered Into Agreement With TAP Pharmaceutical 15
Flamel Terminates Its Agreement With Bristol-Myers Squibb 16
Key Competitors 17
Key Employees 17
Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Appendix 19
Methodology 19
About Global Markets Direct 19
Contact Us 19
Disclaimer 19
List of Tables
Flamel Technologies S.A., Pharmaceuticals & Healthcare, Deals By Year, 2004 to YTD 2009 4
Flamel Technologies S.A., Pharmaceuticals & Healthcare Deals By Type, 2004 to YTD 2009 5
Flamel Technologies S.A., Pharmaceuticals & Healthcare, Deals By Region, 2004 to YTD 2009 6
Flamel Technologies S.A., Deals By Sector, 2004 to YTD 2009 7
Flamel Technologies S.A., Pharmaceuticals & Healthcare, Deals Summary, 2004 to YTD 2009 8
Flamel Technologies Enters Into Licensing Agreement With Merck Serono 9
Flamel Technologies Enters Into Licensing Agreement With Merck Serono 10
Flamel Technologies Enters Into Agreement With Wyeth Pharmaceuticals 11
Flamel Technologies Entered Into Co-Marketing Agreement With RHEI Pharmaceuticals 12
Flamel Terminates Agreement With TAP Pharmaceutical 13
Flamel Terminates Licensing Agreement With Biovail 14
Flamel Entered Into Agreement With TAP Pharmaceutical 15
Flamel Terminates Its Agreement With Bristol-Myers Squibb 16
Flamel Technologies S.A., Key Employees 17
Flamel Technologies S.A., Other Locations 18
List of Figures
Flamel Technologies S.A., Pharmaceuticals & Healthcare, Deals By Year, 2004 to YTD 2009 4
Flamel Technologies S.A., Pharmaceuticals & Healthcare, Deals by Type, 2004 to YTD 2009 5
Flamel Technologies S.A., Pharmaceuticals & Healthcare, Deals By Region, 2004 to YTD 2009 6
Flamel Technologies S.A., Pharmaceuticals & Healthcare, Deals by Sector, 2004 to YTD 2009 7
Flamel Technologies S.A. - Pharmaceuticals & Healthcare - Deals and Alliances Profile Page 2/4

3. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
If you have any questions please visit http://www.reportlinker.com/notify/contact
Order Information
Please verify that the product information is correct and select the format(s) you require.
Flamel Technologies S.A. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Product Formats
Please select the product formats and the quantity you require.
Digital Copy--USD 250.00 Quantity: _____
Contact Information
Please enter all the information below in BLOCK CAPITALS
Title: Mr Mrs Dr Miss Ms Prof
First Name: _____________________________ Last Name: __________________________________
Email Address: __________________________________________________________________________
Job Title: __________________________________________________________________________
Organization: __________________________________________________________________________
Address: __________________________________________________________________________
City: __________________________________________________________________________
Postal / Zip Code: __________________________________________________________________________
Country: __________________________________________________________________________
Phone Number: __________________________________________________________________________
Fax Number: __________________________________________________________________________
Flamel Technologies S.A. - Pharmaceuticals & Healthcare - Deals and Alliances Profile Page 3/4

4. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Payment Information
Please indicate the payment method, you would like to use by selecting the appropriate box.
Payment by credit card Card Number: ______________________________________________
Expiry Date __________ / _________
CVV Number _____________________
Card Type (ex: Visa, Amex…) _________________________________
Payment by wire transfer Crédit Mutuel
RIB : 10278 07314 00020257701 89
BIC : CMCIFR2A
IBAN : FR76 1027 8073 1400 0202 5770 189
Payment by check UBIQUICK SAS
16 rue Grenette – 69002 LYON, FRANCE
Customer signature:
Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at
http://www.reportlinker.com/index/terms
Please fax this form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
Flamel Technologies S.A. - Pharmaceuticals & Healthcare - Deals and Alliances Profile Page 4/4